125742 S2 M3 32p52 analytical procedure subvis particulate matter

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

1

Document text

BNT162b2
3.2.P.5.2 Analytical Procedures
Subvisible Particulate Matter 
PFIZER CONFIDENTIAL
Page 13.2.P.5.2. SUBVISIBLE PARTICULATE MATTER 
The anal ytical procedure for measuring subvisible particulate matter in BNT162b2 drug 
product is performed using the  test in accordance with USP 
<787>and Ph. Eur. 2.9.19.
090177e19700aef1\Approved\Approved On: 12-May-2021 07:26 (GMT)
(b) (4)
FDA-CBER-2021-5683-1149278